of great value in the rapid purification of proteins to We present the directed immobilization of recombi-high degrees of purity. The antibody could either be nant antibody fragments as ligands for general immu-used as affinity matrix in a one-step purification of noaffinity chromatography methods. It is based on natural proteins or be used for recombinant proteins fusion proteins of scFv fragments with several chitin-in conjunction with methods based on peptide tags (5, binding domains which can be immobilized directly 6) or even be directed against the peptide tag itself, from a crude bacterial lysate on inexpensive chitin thereby using the same tag twice in an orthogonal manbeads for the purification of proteins without any gradi-ner, as each column will remove other impurities. Howent or detector. It has been used with a positive pressure ever, because of the large investment of time and effort manifold, allowing the parallel processing of 24 differ-and thus cost in generating monoclonal antibodies ent samples on a milligram scale, as convenient as plas-(mAb) and producing them at the scale required, IAC mid isolation. The method is demonstrated with several has only rarely been used in the purification of proteins anti-protein antibodies. In addition, methods are pre-on milligram scales. As the mAb will normally be cova- taining recombinant antibodies with the desired specificity. Therefore, IAC with antibody fragments would be particularly attractive for the parallel purification Because of its high affinity and selectivity, immunoaf-of proteins for proteomics projects. However, no convefinity chromatography (IAC) 3 (1-4) could be in principle nient method has been described for immobilizing the recombinant antibody fragments. Random crosslinking 1 Present address: Nanotype GmbH, Lochhamer Schlag 12, (14)(15)(16)(17) to the columns may obstruct the binding site,
chance such that it interferes with antigen binding. The 1) are based on the pAK series (27). The dHLX part of pAK500 was replaced by a linker-CBD fragment via directed immobilization strategies of mAbs (18) rely on their Fc parts, e.g., coupling via their carbohydrate EcoRI and HindIII. The linker-CBD fragment was amplified out of the plasmid pTYB1 (New England Biolabs, moieties or coupling by first binding to protein A or protein G columns, followed by crosslinking. Evidently, Beverly, MA) using the primers CBD5Ј AvrII and CBD3Ј NheI. CBD5Ј AvrII, 5Ј-CATCCGGAATTCGthese methods cannot be applied to recombinant antibody fragments. If instead a tag is used for directed GCGGTGGCTCCGAAGGCGGTGGCAGCGAAGG-TGGCGGCCTAGGCACCACAAATCCTGGTG-3Ј, enimmobilization of the antibody fragment, which would then be bound by another protein, e.g., streptavidin coding the linker sequence (SGAEFGGGSEGGG-SEGGGLG) including an EcoRI and an AvrII site. (19, 20) , this other protein will have to be purified and immobilized first, dramatically adding to the cost of CBD3Ј NheI, 5Ј-GTACCCAAGCTTAGCTAGCTTGA-AGCTGCCACAAG-3Ј, introduced a NheI site and a using such columns on a large scale.
In this paper we introduce a new concept to simulta-HindIII site. The EcoRI site was used to clone a mIgG3hinge-dHLX fragment (derived from pACKdHLX neously solve all of the above problems and provide a general approach for quickly preparing any immunoaf-(28)) for dimerization (Fig. 1) . The NheI site allowed cloning of a second CBD fragment also amplified out finity column from recombinant antibody fragments expressed in Escherichia coli in a one-step procedure with of pTYB1, including the linker sequence. The primers CBD5Ј EcoRI, 5Ј-CCGGAATTCGCTAGCGGTGGCCinexpensive column material. Therefore, many different and even very large affinity columns can be pre-TGACC-3Ј, and CDB3Ј NheI were used to introduce NheI sites at both ends. The resulting plasmids were pared very fast, and a general technology for highthroughput parallel protein purification on multimilli-called pKB100 wt (one CBD), pKB100dHLX wt (dimeric miniantibody-two CBDs), pKB100 wtilwt gram scales is obtained, as is needed, e.g., in structural genomics projects.
(tandem CBDs), and pKB100dHLX wtilwt (dimeric miniantibody-two tandem CBDs). The ribosome-bindThe concept relies on making fusion proteins of an antibody fragment with engineered variants of a carbo-ing site (RBS) was exchanged for the stronger T7G10 RBS of pAK400 (27) and the gene for coexpression of hydrate-binding domain. While such fusions, binding, e.g., to cellulose or chitin, have been used to purify the Skp was introduced (29) resulting in the pKB200 series ( Fig. 1 ). The exchange of cysteine at position 30 (amino fusion with the protein of interest on a carbohydrate column with subsequent cleavage of the partners (21, acid 30 of the isolated CBD, according to the numbering 22) or simply to immobilize proteins (23, 24), in our approach the immobilized fusion is used to purify a ligand of the fusion. We have optimized the fusion construct and found as the best format single-chain Fv antibody fragments (scFv fragments) with two chitinbinding domains (CBDs) C-terminally fused. An E. coli crude extract containing the scFv-CBD fusion protein is passed over chitin beads, by which the fusion protein is selectively immobilized, obviating the need for its prior purification. We demonstrate this principle with scFv fragments of several different specificities. Purifications have been carried out without any detector using gravity flow columns in combination with a positive pressure manifold, allowing the parallel purification of milligram amounts of 24 different samples in 6 h, including column preparation with fresh antibodies.
We also used an antibody against the His tag. This column can be put in series to an immobilized metal ion affinity column (IMAC) (25, 26), thereby leading to a generic rapid protein purification for His-tagged proteins using two different purification principles on FIG. 1. Starting plasmid pKB2scFvCBD for cloning and expression the same tag.
of scFv-CBD fusion proteins. The plasmid is a derivative of the pAK series (27): The plasmid has a lac promoter and the strong RBS of pAK400 (27) . Fusion proteins are expressed in the periplasm coex-
MATERIALS AND METHODS
pressing the periplasmic folding factor Skp (29) regulated by its own promotor. Also represented are the restriction sites used for cloning Plasmid construction. The plasmids for the peri-of the dHLX fragment (28)-EcoRI-and for the second linker-CBD fragment-NheI.
plasmic expression of scFv-CBD fusion proteins (Fig. of NEBs pTYB vector series; amino acid 677 in whole Batch binding experiment. Cell pellets of the antiHis tag fusion proteins were resuspended in TBST chitinase A1, see PDB code 1ED7 (30)) to serine and to alanine was performed by site-directed mutagenesis of buffer (50 mM Tris/HCl, pH 8, 1 M NaCl, 0.1 mM EDTA, 1% Triton X-100) using 1 ml of buffer per 1 g of cells. all CBD fragments. The gene for the anti-His tag scFv fragment (mut12) (M. Kaufmann et al., manuscript in DNase I (Roche Diagnostics, Basel, Switzerland) was added and cell disruption was achieved by French press press) was cloned as SfiI cassette replacing the tetresistance cassette. The scFv fragments directed lysis. After centrifugation (Sorvall SS34, 20,000 rpm, 4ЊC, 30 min) the supernatant was passed through a against FkpA (6B1, 7B2, 9B3, and 11B4) as well as the scFvs K14G2 (anti-gpD scFv) and N7A9 (anti-SHP 0.22-m filter (Millipore, Volketswil, Switzerland). To compensate for differences in expression levels of the scFv) were selected out of the human combinatorial antibody library (HuCAL) (12) by two rounds of auto-constructs, estimated from Western blot analysis, crude extracts were diluted with TBST buffer to different exmated phage display (31). Nonsymmetrical SfiI sites (27) were attached to the scFv cassettes of the HuCAL tents. For the binding experiment those diluted crude extracts, now containing the same amount of fusion series by PCR and cloned into a pKB200 derivative containing gIIIpss (27) as stuffer, necessary to supply protein, were shaken with equilibrated chitin beads (New England Biolabs). Equilibrated chitin beads were the EcoRI site. All HuCAL scFvs described here were introduced as MfeI/EcoRI fragments, thus removing the prepared by using 100 l of beads in an ethanol suspension and washing them three times with 1 ml of TBST second SfiI site. The stuffer fragment was then exchanged for the CBDilCBD cassette by EcoRI/HindIII buffer in a 2-ml Eppendorf tube. To these beads 500 l of diluted crude E. coli extract containing the scFv-CBD cloning (Fig. 1) .
fusion proteins was added. The mixture was shaken at Expression of scFv-CBD fusions. The plasmids en-4ЊC for 1 h. The beads were washed three times with coding the 12 different anti-His tag-CBD fusion pro-1 ml of TBST buffer. One aliquot was taken and anateins ( Figs. 2 and 3 ; pKB2Hmut12 series, see Fig. 1 ) lyzed by SDS-PAGE to ensure that the same amount were transformed in the E. coli K12 strain SB536 (32) of each fusion protein had bound to the beads. The (F Ϫ , WG1, ⌬fhuA (tonA), ⌬hhoAB (SacII), shh). Small-dissociation from the beads was determined by shaking scale expressions were performed at 25ЊC using 50 ml the beads in 200 l elution buffer (50 mM 3-[cycloof SB medium (20 g/liter tryptone, 10 g/liter yeast ex-hexylamino]-1-propane-sulfonic acid caps) (Sigma, tract, 5 g/liter NaCl, 50 mM K 2 HPO 4 ) containing 30 g/ Buchs, Switzerland)/NaOH, pH 10, 500 mM NaCl, 0.1 ml chloramphenicol. Cultures were inoculated from a mM EDTA) for 1 h at 4ЊC. The beads were sedimented 5-ml preculture to OD 550 ϭ 0.1. Expression was induced and the supernatant containing dissociated molecules with 1 mM IPTG at an OD 550 between 1.0 and 1.5. Cells was analyzed by an anti-FLAG blot. were harvested 3 h after induction by centrifugation.
SDS-PAGE and Western blot analysis. SDS-PAGE Cell pellets were resuspended in MBS buffer (20 mM analyses were carried out under reducing conditions Mes/NaOH, pH 6.5, 500 mM NaCl, 0.1 mM EDTA), according to standard protocols using 12 and 15% polynormalized to their end OD 550 using 2.5 ml of MBS acrylamide gels. Western blots with the monoclonal per 1 unit OD 550 . Whole cell extracts were prepared by anti-FLAG antibody M1 were carried out as described French press lysis at 10,000 psi and 1 ml of crude extract (37, 38) . was centrifuged in an Eppendorf tube for 60 min at maximum speed and 4ЊC. The supernatants containing Preparation of crude extracts for chromatography exthe soluble material and the pellets were analyzed in periments. Cell pellets expressing the fusion proteins an anti-FLAG blot. Large-scale expressions of the scFv-(scFv-C30A-C30A constructs) used for chromatogra-CBD fusion proteins were carried out in culture vol-phy experiments were resuspended in TBST buffer usumes from 750 ml to 1 liter in 5-liter baffled shake ing 5 ml of buffer per 1 g of cells. After addition of flasks as described for the small cultures.
DNase I, cell disruption was achieved by French press lysis. The suspension was clarified by centrifugation at Expression of antigens. The expression of FkpA (33) , maximum speed for 60 min and 4ЊC (Sorvall, SS34) and GpHD (34), GpHDL-cCrk (34) , and SHP (35) was carfiltration through a 0.22-m filter. The same procedure ried out exactly following published protocols. Hiswas performed with antigen cell pellets, but using MBS tagged proteins (scFv 4D5-His, GroES-His, PhoAbuffer (20 mM Mes/NaOH, pH 6.5, 500 mM NaCl, 0.1 His, CS-His, and GFP-His) were expressed in the E. mM EDTA).
Column chromatography. Chromatography experiat 25ЊC in 5-liter baffled shake flasks using dYT me-ments were performed using SPE columns, usually dium (16 g/liter tryptone, 10 g/liter yeast extract, 5 g/ mounted in a positive pressure manifold (Fig. 4) (Varian liter NaCl) and were induced at OD 550 ϭ 1 with 1 mM Analytical Instruments Inc., Walnut Creek, CA). Empty SPE columns (Varian Bond Elut LRC, 10-ml columns) IPTG (36) . Cells were harvested 5 h after induction.
were filled with 1.5 ml ethanol suspension of chitin literature (21-24) (see also New England BioLabs' Impact T7 kit instruction manual), but consistent with beads (corresponding to approximately 1 ml settled beads) and after sedimentation a porous PTFE filter quantitative determinations of the affinity of a cellulose binding domain from Trichoderma reesei to cellulose disk was placed on top of the settled column bed. Columns were equilibrated with 20 ml of TBST buffer. For (40, 41) . Consequently, stable binding to the beads, which is observed under many conditions, relies on the equilibration a pressure of 0.4 bar was applied to the columns. Next, between 1.5 and 6 ml of scFv-C30A-high molar concentration of chitin on the beads and is dynamic in nature (41, 42) . C30A crude extract was loaded containing between 0.4 and 2 mg of fusion protein.
No pressure was applied to
We therefore investigated the use of fusion proteins having more than one CBD. We fused two CBDs in the columns during loading of CBD fusions containing crude extracts. The columns were washed at 0.2 bar tandem, dimerized the scFv to a miniantibody CBD fusion, or combined both strategies to generate a prowith 2 ml (2 column vol, cv) of TBST buffer and equilibrated with 8 ml (8 cv) of MBS buffer also at 0.2 bar. tein with four CBDs (Fig. 2) . While all of these constructs showed better binding (Fig. 3B , wt constructs), In the next step 2-3 ml crude extract containing the antigen was loaded without applying any pressure. The periplasmic expression was decreased compared to the original scFv-CBD construct (Fig. 3A , wt constructs). columns were washed with 20 ml (20 cv) MBS at 0.2 bar. For the anti-FkpA fusions an additional washing As the CBD used contains a single unpaired cysteine, the periplasmic production of the fusion proteins is imstep at pH 3.2 (100 mM glycine/HCl, pH 3.2, 500 mM NaCl, 0.1 mM EDTA; 10 ml of buffer at 0.2 bar) was paired. We therefore replaced the cysteine residue by serine or alanine, and indeed both mutations lead to included (see Results). Elution of the different antigens was performed with 2 ml of elution buffer as follows: much better expression of all constructs possessing two or four CBDs. Two constructs (scFv-C30S-C30S and Elution from the anti-His tag columns could be achieved at pH 10 (50 mM CAPS/NaOH, pH 10, 500 mM NaCl, scFv-C30A-C30A) showed about the same expression level as the simple scFv-CBD fusion. 0.1 mM EDTA). All four different anti-FkpA columns were eluted at pH 2 (100 mM glycine/HCl, pH 2, 500
For their use as affinity ligands stable binding of the fusion proteins to the column material is decisive. We mM NaCl, 0.1 mM EDTA). SHP could be either eluted at pH 3.2 or pH 10, while the elution of GpD or GpD therefore investigated the dissociation of all constructs from the chitin beads under elution conditions (used fusion proteins was more effective at pH 3.2. Eluted fractions at pH 3.2 were neutralized with 17 l 1 M for the anti-His tag scFv fragment). The same amount of fusion protein was bound to the beads for all constructs. Tris per milliliter, for the fractions eluted at pH 2 100 l of 1 M Tris was required per milliliter.
After shaking the beads for 1 h under elution conditions, the supernatant containing the dissociated molecules Immobilized metal ion affinity chromatograwas analyzed by an anti-FLAG blot (Fig. 3B) . The rephy. For the second purification step of the His-tagged sults suggest that both mutations result in weaker proteins Ni-NTA Superflow (Qiagen, Basel, Switzerbinding of the single CBDs, but there is almost no dissoland) was used. As for the IAC runs, all IMAC expericiation detectable for the scFv-CBD-CBD and the ments were performed using the positive pressure manminiAb-CBD-CBD fusion proteins. Even though miniifold. The reservoirs were filled with 0.5 ml sedimented antibody-CBD fusions contain two CBDs as do the Ni-NTA material. The gel bed was covered with a PTFE scFv-CBD-CBD constructs, they showed more leakage disc and equilibrated with 20 ml of binding buffer (50 from the chitin beads. This may be due to some dissociamM Tris/HCl, pH 8, 500 mM NaCl, 20 mM imidazole). tion of the miniantibody over time. Summarizing these The pH 10-eluted fractions of the anti-His tag affinity results, the scFv-C30A-C30A and the scFv-C30S-columns were directly loaded. The columns were C30S fusion proteins show the highest expression level washed with 20 ml of binding buffer. Elutions were and sufficiently stable binding to the column material. carried out with 2 ml of elution buffer (50 mM Tris/ Based on homology to other non-cysteine-containing HCl, pH 8, 500 mM NaCl, 200 mM imidazole).
CBDs (30) we decided to use the scFv-C30A-C30A construct as affinity ligand for our experiments.
RESULTS
To demonstrate the general applicability of our method we cloned scFv-C30A-C30A fusion proteins of Construction and expression of CBD fusion proteins. The CBD (21, 30, 39) of Bacillus circulans WL-six additional scFv fragments. All of them were selected out of the HuCAL (12), a naïve fully synthetic scFv 12 chitinase A1 (SwissProt No. P20533) was used. Preliminary tests of a fusion consisting of one CBD and a library with a diversity of 2 ϫ 10 9 , by two rounds of phage display (31). Four scFv fragments with different mutated version of the anti-His tag scFv 3D5 (36) showed bleeding from the column, suggesting that the frameworks for V H and V L as well as different CDR3s
were selected as recognizing the E. coli protein FkpA binding of one CBD to chitin must be very weak. This observation is in contrast to expectations raised in the (33, 43). Using similar procedures, a scFv fragment specifically recognizing either the -phage coat protein performance of four different anti-FkpA scFv fragments 6B1, 7B2, 9B3, and 11B4. The screening for elution gpD (34, 35) or the homologous protein SHP from phage 21 were selected.
conditions showed that elution of the antigen was only possible at pH 2, independent of the scFv immobilized. Affinity purification. Most of the chromatography This tight binding made it possible to introduce an addiexperiments were carried out using a positive pressure tional washing step at pH 3.2, removing some further manifold (Fig. 4) . Sample processing without any deteccontaminants. We immobilized the same defined tor became possible after some preliminary tests to deamount of the scFv fusion proteins (0.4 mg) on the termine buffer volumes necessary for washing and elucolumns and overloaded them with FkpA. After washtion of the columns. The low overpressure applied to ing the columns we could elute most FkpA from the the columns lead to a more uniform flow rate than 7B2 and 11B4 columns. While there was one additional under gravity flow.
band visible when the 11B4 scFv fragment was used To demonstrate the performance of the immobilized all other columns yielded pure protein (Fig. 5B) . The scFv-C30A-C30A fusion proteins as affinity ligands experiments in Figs. 5A and 5B show that the antibody we show three different series of chromatography exitself is the most crucial determinant of purification periments. One series demonstrates purifications with quality and that with suitable antibodies, highly pure the anti-gpD and anti-SHP ligands (Fig. 5A) . gpD by protein is obtained and no significant contaminants are itself and the his tagged kinase fusion protein gpHDintroduced by the immobilization strategy. cCrk (34) bind to the anti-gpD column and can be eluted
The above examples have been carried out to investieither at pH 3.2 or pH 10, and for this scFv fragment gate the range of applications of the immobilization elution at pH 3.2 is more effective. SHP binds to its concept described and the influence of the scFv chosen cognate scFv fragment and can be eluted at pH 3.2 and and to demonstrate that IAC can be easily standardized pH 10 with the same recovery.
In a second series of experiments we investigated the for parallel purification of different samples. A model optimal binding buffer for all scFv-C30A-C30A fusion proteins. Further experiments showed that in the antigen loading step Triton X-100 was not necessary and that 500 mM NaCl was sufficient to reduce protein binding to chitin. We then determined the capacity of the column for scFv-C30A-C30A fusion proteins and for the desired antigen. Batch binding experiments suggested that the capacity of chitin for CBD fusions is extremely high. Indeed, 100 l of sedimented chitin beads bound approximately 5 mg of the anti-His tag-C30A-C30A fusion protein. Nevertheless, dynamic conditions are different, since some binding sites will not be accessible under flow conditions because of diffusion limitation, and bound molecules will dissociate from their binding sites and will be transported by the buffer flow resulting in a slow migration of the ligands over the column. Therefore, we recommend not to load more than 2 mg of scFv-C30A-C30A fusion proteins per 1 ml of settled chitin beads. This "dynamic capacity" is still in the upper range described for conventional affinity columns with monoclonal antibodies (2) . To determine the capac- system-anti-His tag scFv and His-tagged GFP (44)-has been used to develop the protocol at different scales and in particular optimize the buffers applied for the purifications described above. Binding experiments with the anti-His tag-C30A-C30A fusion protein in different buffers showed that the fusion proteins bound completely in most buffers, including pH values between 3 and 10, NaCl concentrations between 0 and 1 M, and some additives such as 1% Triton X-100, 0.4 M arginine, 0.1% SDS. These results are in accordance with results described in the literature (21) and suggest that the equilibrium binding constant is not influenced much by the buffer components mentioned above. As the CBD is a very hydrophobic domain (30), membrane components associated with the CBDs initially clogged the columns and appeared as contaminants in the FIG. 4 running several identical columns on the manifold in following proteins: GroES-His (36, 45) (seven His tags), the scFv fragment 4D5-His (46) (one His tag), citrate parallel, by scaling up the gravity columns themselves (up to 5 ml) or by using conventional chromatographic synthase (36) (CS-His, two His tags), GFP-His (one His tag), and E. coli alkaline phosphatase (47) (PhoAequipment with pumps. We purified 20 mg His-tagged GFP on 17 ml beads with 27 mg scFv fusion (Fig. 5C) . His, two His tags). Even though there are a different numbers of His tags on the different antigens, we could This procedure should be directly scalable to multigram amounts with any scFv fragment. not detect any difference in the elution behavior of the antigens, as most antigen was found in the first 2-ml Two-step purification of His-tagged proteins. The fraction of the elution (data not shown). The eluted above results demonstrate that IAC with the scFv fragfractions again show a very high degree of purity (Fig. ments described could provide a tool for the one-step 6, lanes A). They were directly loaded on the Ni-NTA purification of the respective antigen to a high degree column equilibrated with binding buffer containing 20 of purity (Fig. 5) which might be sufficient for many mM imidazole to reduce unspecific binding. With the applications. However, we also wanted to provide a gecoupled IMAC step we could clearly further reduce the neric technology to obtain high purity proteins with as contaminants (Fig. 6, lanes B ). In conclusion, this twosimple a procedure as plasmid purification. We thus step method, which uses a positive pressure manifold developed a coupled anti-His tag/IMAC procedure in for both columns, is a valuable tool for the generic, easy, which the same tag is recognized twice but by totally and fast purification of many His-tagged proteins in different physical principles, and different contamiparallel on milligram scales. nants should thus be removed. To avoid any dialysis steps and allow direct coupling of the columns we investigated elution conditions without imidazole for the anti-His tag affinity column and found that elution of DISCUSSION His-tagged GFP was complete at pH 10 and resulted in a sharp peak. This convenient elution behavior is
In this work we present a novel strategy for the directed immobilization of recombinant antibody scFv the result of this scFv fragment recognizing a protonated, C-terminally located His tag (36) which becomes fragments. Fusions with cysteine-free tandem CBDs were designed for high expression level and tight binddeprotonated when the pH value is increased. To demonstrate the generality of the method we tested the ing to the chitin matrix. The migration of the tandem Streptavidin matrices (19, 20) , which are rather expensive, as streptavidin itself must be purified and chemically coupled to an activated matrix, have been used either with a tag which is biotinylated in vivo, but only 15% of the Fab fragment was biotinylated, leading to a low yield of immobilized molecules. If instead a weakbinding purely peptidic tag (Strep tag) is used (19), more functional molecules can be immobilized, but the whole complex of Fv fusion protein and antigen is eluted by biotin, thus requiring a second purification step. In contrast, our method yields almost 100% active immobilized molecules that remain bound on the column while the antigen is eluted.
Our concept should also be useful for therapeutic proteins, which normally must not carry a tag. Even though IAC with mAbs would provide a powerful purification, its use on the large scale required is economi- scalable technology described here makes this an attractive option for the first capturing step. Similarly, the simultaneous purification of untagged natural proteins for proteomics can make use of the same technol-CBD fusions over the column is very slow and the equilibrium of chitin-bound and dissociated CBD fusions is ogy on a very small scale.
Finally, our method is also useful for His-tagged pronot shifted by the elution conditions, which leads to a selective dissociation of the antigen from the scFv teins. In many cases, His-tagged proteins are not pure enough after IMAC for the desired application and refragment. Our results with seven different scFv fragments used to purify nine antigens demonstrate that quire a second step. Parallel purification has been implemented on small scales (50), but the enzymatic activthis concept can be generally applied for IAC and yields highly pure protein when a suitable scFv fragment is ity studies did not depend on having very pure samples.
To maximize purification, gradients, and UV detectors used.
Compared to affinity chromatography methods using are needed in IMAC, making parallel purification on milligram scales impractical. Here we use two columns peptides (48) or other scaffolds (49) as ligands or to conventional IAC applications with mAbs our method in series which both recognize the His tag but with different physical principles. Since the eluant of the has several advantages: (i) Instead of mAbs, whose production is expensive and time-consuming, we use scFv anti-His scFv column can be directly loaded onto the IMAC column and since no gradients or detectors are fragments which take advantage of modern library technologies and can be easily expressed in E. coli in necessary, a very efficient and generic parallel protein purification is possible, inspired by modern parallel large amounts. (ii) As the scFv fusion protein is coupled via the biological affinities of the CBD domains it is plasmid purification. The concept can be generalized from scFv proteins to any other protein with an affinity not involved in the immobilization procedure. This means that in contrast to conventional methods (1, 15, for the target molecule. Furthermore, this concept may also be useful to provide a capture surface for protein 16) no loss in binding capacity occurs. (iii) The use of random chemical coupling requires expensive activated chip technology.
We believe that this technology may be of great value matrices and purified ligands. Our method uses nonactivated carbohydrates, where the scFv fusion proteins in the purification of proteins from small scales to large scales and may finally lead to a generic protein purificabind selectively without the need for prior purification. (iv) Easy standardization and little instrumentation tion. during the purifications make parallel sample processing possible. ACKNOWLEDGMENTS There are several approaches for immobilizing recombinant antibody fragments reported in the literature.
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